This is a preview of subscription content, log in via an institution to check access.
Reference
Ruggeri M, et al. [Economic evaluation and budget impact analysis of S-1 (tegafur/gimeracil/oteracil) in patients with advanced gastric cancer]. Pharmacoeconomics - Italian Research Articles : 31 Jul 2013. Available from: URL: http://dx.doi.org/10.1007/s40276-013-0007-1
Rights and permissions
About this article
Cite this article
S-1 produces savings in Italy. PharmacoEcon Outcomes News 685, 7 (2013). https://doi.org/10.1007/s40274-013-0646-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0646-5